Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease
Clinical trial NCT05969743 · UNKNOWN
Trial details
- NCT number
- NCT05969743
- Sponsor
- Rabin Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2025-04-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.